249 related articles for article (PubMed ID: 36882658)
1. Fecal microbiota transplantation for induction of remission in Crohn's disease: a systematic review and meta-analysis.
Zhou S; Cui Y; Zhang Y; Zhao T; Cong J
Int J Colorectal Dis; 2023 Mar; 38(1):62. PubMed ID: 36882658
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for Crohn's disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Wei W; Li Z
Tech Coloproctol; 2021 May; 25(5):495-504. PubMed ID: 33759066
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation therapy in Crohn's disease: Systematic review.
Fehily SR; Basnayake C; Wright EK; Kamm MA
J Gastroenterol Hepatol; 2021 Oct; 36(10):2672-2686. PubMed ID: 34169565
[TBL] [Abstract][Full Text] [Related]
4. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Paramsothy S; Paramsothy R; Rubin DT; Kamm MA; Kaakoush NO; Mitchell HM; Castaño-Rodríguez N
J Crohns Colitis; 2017 Oct; 11(10):1180-1199. PubMed ID: 28486648
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
[TBL] [Abstract][Full Text] [Related]
6. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Fang H; Fu L; Wang J
Biomed Res Int; 2018; 2018():8941340. PubMed ID: 30302341
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.
Zeng L; Deng Y; Yang K; Chen J; He Q; Chen H
Front Immunol; 2022; 13():944387. PubMed ID: 36248877
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
Sokol H; Landman C; Seksik P; Berard L; Montil M; Nion-Larmurier I; Bourrier A; Le Gall G; Lalande V; De Rougemont A; Kirchgesner J; Daguenel A; Cachanado M; Rousseau A; Drouet É; Rosenzwajg M; Hagege H; Dray X; Klatzman D; Marteau P; ; Beaugerie L; Simon T
Microbiome; 2020 Feb; 8(1):12. PubMed ID: 32014035
[TBL] [Abstract][Full Text] [Related]
9. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
Yang Z; Bu C; Yuan W; Shen Z; Quan Y; Wu S; Zhu C; Wang X
Dig Dis Sci; 2020 Jan; 65(1):150-157. PubMed ID: 31367877
[TBL] [Abstract][Full Text] [Related]
11. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
[TBL] [Abstract][Full Text] [Related]
12. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
[TBL] [Abstract][Full Text] [Related]
13. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
[TBL] [Abstract][Full Text] [Related]
15. Low dose naltrexone for induction of remission in Crohn's disease.
Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
[TBL] [Abstract][Full Text] [Related]
16. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
Khanna R; Preiss JC; MacDonald JK; Timmer A
Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
[TBL] [Abstract][Full Text] [Related]
18. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
19. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
20. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
